Fresenius SE Total Liabilities 2016-2023 | FSNUY

Fresenius SE total liabilities from 2016 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Fresenius SE total liabilities for the quarter ending September 30, 2023 were $49.028B, a 5.43% increase year-over-year.
  • Fresenius SE total liabilities for 2022 were $46.566B, a 7.77% decline from 2021.
  • Fresenius SE total liabilities for 2021 were $50.488B, a 8.8% increase from 2020.
  • Fresenius SE total liabilities for 2020 were $46.404B, a 2.49% increase from 2019.
Fresenius SE Annual Total Liabilities
(Millions of US $)
2022 $46,566
2021 $50,488
2020 $46,404
2019 $45,277
2018 $48,766
2017 $35,506
2016 $28,801
2015 $27,945
Fresenius SE Quarterly Total Liabilities
(Millions of US $)
2023-09-30 $49,028
2023-06-30 $49,049
2023-03-31 $47,637
2022-12-31 $46,566
2022-09-30 $46,504
2022-06-30 $46,909
2022-03-31 $47,727
2021-12-31 $50,488
2021-09-30 $50,582
2021-06-30 $51,225
2021-03-31 $49,975
2020-12-31 $46,404
2020-09-30 $49,238
2020-06-30 $46,579
2020-03-31 $46,352
2019-12-31 $45,277
2019-09-30 $44,550
2019-06-30 $44,451
2019-03-31 $44,472
2018-12-31 $48,766
2018-09-30 $47,563
2018-06-30 $48,421
2018-03-31 $48,698
2017-12-31 $35,506
2017-09-30 $37,527
2017-06-30 $35,062
2017-03-31 $34,632
2016-12-31 $28,801
2016-09-30 $27,653
2016-06-30 $28,650
2016-03-31 $26,958
2015-12-31 $27,945
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.911B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.437B 15.95
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00